Copernicus Capital Management, LLC
Filing Date
Global Rank
#5,697
/ 5,929
▲ 66
· as of Sep 2021
Top Industry
Biotechnology
40.8%
3Y Alpha vs SPY
-23.4%
Period ended 4 years ago
Filed Nov 15, 2021 · 4y
7 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-7.2%
SPY
+76.0%
Annualised alpha
-23.2%
Max drawdown
−42.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
12 positions · as of Sep 30, 2021 · Δ vs Jun 30, 2021Top Position
17.0%
−25.4 pts
Top 5
65.5%
−30.6 pts
Top 10
97.0%
−3.0 pts
HHI
1,110
Diversified−1,494
Portfolio Trend
7 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2021| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $7,604,200 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FATE | Fate Therapeutics Inc | +2,000 | 12,000 | $711,240 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | −3,000 | 17,000 | $592,790 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PFE | Pfizer Inc | 30,000 | $1,290,300 | |
| TMO | Thermo Fisher Scientific Inc. | 2,000 | $1,142,660 | |
| TDOC | Teladoc Health, Inc. | 7,000 | $887,670 | |
| BMRN | Biomarin Pharmaceutical Inc | 11,000 | $850,190 | |
| JNJ | Johnson & Johnson | 5,000 | $807,500 | |
| ALLO | Allogene Therapeutics, Inc. | 15,000 | $385,500 | |
| MDT | Medtronic plc | 3,000 | $376,050 | |
| PRQR | ProQR Therapeutics N.V. | 40,000 | $334,800 | |
| IMTX | Immatics N.V. | 10,000 | $130,000 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 10,000 | $95,500 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
4 positions
12 positions ·
$7,604,200 total
· as of Sep 30, 2021
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PFE |
Pfizer Inc
Healthcare
|
NEW | 30,000 | $1,290,300 | 16.97% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
NEW | 2,000 | $1,142,660 | 15.03% | |
| TDOC |
Teladoc Health, Inc.
Healthcare
|
NEW | 7,000 | $887,670 | 11.67% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 11,000 | $850,190 | 11.18% | |
| JNJ |
Johnson & Johnson
Healthcare
|
NEW | 5,000 | $807,500 | 10.62% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Added | 12,000 | $711,240 | 9.35% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Reduced | 17,000 | $592,790 | 7.80% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
NEW | 15,000 | $385,500 | 5.07% | |
| MDT |
Medtronic plc
Healthcare
|
NEW | 3,000 | $376,050 | 4.95% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
NEW | 40,000 | $334,800 | 4.40% | |
| IMTX |
Immatics N.V.
Healthcare
|
NEW | 10,000 | $130,000 | 1.71% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
NEW | 10,000 | $95,500 | 1.26% |